Sugi Predict

Sugi Predict / Compounds / SCHEMBL4387218

SCHEMBL4387218

SCHEMBL4387218

C[C@@H](C(=O)O)N(O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ ALOX5 P09917 1/20 0.41
▸ GLA P06280 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ PGR P06401 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ ADRA2B P18089 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ HRH1 P35367 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ PTGS2 P35354 1/20 0.39
▸ CYP2D6 P10635 1/20 0.38
▸ SRC P12931 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4387215 1.00 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2NPSR1LMNATP53
SCHEMBL942846 0.85 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2NPSR1LMNATP53
SCHEMBL30536064 0.82 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2NPSR1LMNATP53
SCHEMBL14463144 0.80 NPSR1 (0.44) ALDH1A1SMN1; SMN2NPSR1LMNATP53
SCHEMBL502831 0.80 PTGS2 (0.45) ALDH1A1SMN1; SMN2NPSR1LMNATP53
SCHEMBL93387 0.80 PTGS2 (0.45) ALDH1A1SMN1; SMN2NPSR1LMNATP53
SCHEMBL157605 0.80 PTGS2 (0.45) ALDH1A1SMN1; SMN2NPSR1LMNATP53
SCHEMBL755703 0.78 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2NPSR1LMNATP53
SCHEMBL28995220 0.78 PTGS2 (0.44) ALDH1A1SMN1; SMN2NPSR1LMNATP53
SCHEMBL755702 0.78 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2NPSR1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023120782-A1 ADHESIVE CONDUCTIVE HYDROGEL USING RADIATION CROSSLINKING METHOD, METHOD FOR PREPARING SAME, AND ADHESIVE CONDUCTIVE HYDROGEL SHEET USING SAME 서울방사선서비스주식회사 2023-06-29 — — WO claimed
CN-212432989-U P hydroxy phenyl alanine urine detection test paper box and test paper subassembly 苏州良辰生物仪器试剂有限公司 2021-01-29 — — CN claimed
CN-112213485-A Magnetic nano-microsphere as p-hydroxy phenylalanine urine detection reagent and preparation method thereof 南京迪安医学检验所有限公司 2021-01-12 — — CN claimed
CN-1193979-A Macrolide compounds NOVARTIS AG (CH) 1998-09-23 — — CN claimed
CN-119677541-A Aromatic boron-containing compounds and related insulin analogues 原聚体科技公司 2025-03-21 — — CN disclosed
WO-2023120782-A1 ADHESIVE CONDUCTIVE HYDROGEL USING RADIATION CROSSLINKING METHOD, METHOD FOR PREPARING SAME, AND ADHESIVE CONDUCTIVE HYDROGEL SHEET USING SAME 서울방사선서비스주식회사 2023-06-29 — — WO disclosed
CN-212514284-U P-hydroxy phenylalanine urine detection test paper box and test paper assembly 苏州良辰生物仪器试剂有限公司 2021-02-09 — — CN disclosed
CN-212432989-U P hydroxy phenyl alanine urine detection test paper box and test paper subassembly 苏州良辰生物仪器试剂有限公司 2021-01-29 — — CN disclosed
CN-212432989-U P hydroxy phenyl alanine urine detection test paper box and test paper subassembly 苏州良辰生物仪器试剂有限公司 2021-01-29 — — CN disclosed
CN-212432989-U P hydroxy phenyl alanine urine detection test paper box and test paper subassembly 苏州良辰生物仪器试剂有限公司 2021-01-29 — — CN disclosed
CN-211627380-U Convenient p hydroxy phenyl alanine urine detection test paper box that detects 江苏东博生物医药有限公司 2020-10-02 — — CN disclosed
CN-211627380-U Convenient p hydroxy phenyl alanine urine detection test paper box that detects 江苏东博生物医药有限公司 2020-10-02 — — CN disclosed
US-20080124758-A1 Transmembrane domain removed recombinant human tyrosinase and method of producing the same CHUNG-ANG UNIVERSITY INDUSTRY-ACADEMY COOPERATION FOUNDATION (KR) 2008-05-29 — — US disclosed
EP-1903108-A1 Transmembrane domain-removed recombinant human tyrosinase and method of producing the same Chung-Ang University Industry-Academy Cooperation Foundation (KR) 2008-03-26 — — EP disclosed
CN-1193979-A Macrolide compounds NOVARTIS AG (CH) 1998-09-23 — — CN disclosed
EP-0594645-A1 PROCESS FOR THE PREPARATION OF PURE ISOMERIC FORMS OF 3,3,5-TRIMETHYL CYCLOHEXANOL AND 3,3,5-TRIMETHYL CYCLOHEXANONE AMINO ACID ESTERS PANMEDICA (FR) 1994-05-04 — — EP disclosed
WO-1992022529-A1 PROCESS FOR THE PREPARATION OF PURE ISOMERIC FORMS OF 3,3,5-TRIMETHYL CYCLOHEXANOL AND 3,3,5-TRIMETHYL CYCLOHEXANONE AMINO ACID ESTERS PANMEDICA (FR) 1992-12-23 — — WO disclosed
EP-0261017-B1 AMINO ACID ESTERS OF CYCLOALIPHATIC ALCOHOLS, PROCESS FOR THEIR PREPARATION AND USE AS MEDICINE PANMEDICA S.A. (FR) 1991-03-20 — — EP disclosed
EP-0261017-A1 Amino acid esters of cycloaliphatic alcohols, process for their preparation and use as medicine PANMEDICA S.A. (FR) 1988-03-23 — — EP disclosed
US-3725470-A AMINO ACID DERIVATIVES HOFFMANN LA ROCHE 1973-04-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080124758-A1 Transmembrane domain removed recombinant human tyrosinase and method of producing the same TYR, TH, TMX1 ALDH1A1 1082/4885SMN1; SMN2 4655/4885NPSR1 2483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.